STAT3 and lung carcinoma: Treatment of HCC2429 and H460 lung cancer cells with the JAK2 inhibitor TG101209 led to a reduced phosphorylation of STAT3, inhibition of survivin, increased apoptosis, and decreased cell proliferation [101].